is a clinical stage biopharmaceutical company developing a completely new class of anti-inflammatory therapeutics to treat and prevent human inflammatory disorders.
Saints Capital | 2020 Union St., San Francisco, CA 94123 | (415) 773-2080 | eMail Us
© 2024 All Rights Reserved
© 2022 All Rights Reserved